MedPath

ATROPINE SULFATE

ATROPINE SULFATE INJECTION, USP 1mg/mL

Approved
Approval ID

0060b971-19bd-2849-e063-6294a90afca8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 28, 2024

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATROPINE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1626
Application NumberANDA216120
Product Classification
M
Marketing Category
C73584
G
Generic Name
ATROPINE SULFATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 28, 2024
FDA Product Classification

INGREDIENTS (5)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ATROPINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: 03J5ZE7KA5
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATROPINE SULFATE - FDA Drug Approval Details